TAKEDA PHARMACEUTICALS U.S.A., INC. v. SUN PHARMACEUTICAL INDUSTRIES LTD.
Post Content
TAKEDA PHARMACEUTICALS U.S.A., INC. v. SUN PHARMACEUTICAL INDUSTRIES LTD. Read Post »
Litigation Summary and Analysis: Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Limited (1:26-cv-00785) Executive Summary Azurity Pharmaceuticals, Inc. has filed a
Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma Limited Read Post »
Vertex Pharmaceuticals Incorporated v. Squires (1:26-cv-01934): Litigation Summary, Claims, and Patent-Position Analysis Vertex Pharmaceuticals Incorporated has filed suit against Squires
Vertex Pharmaceuticals Incorporated v. Squires Read Post »
Generic and biosimilar companies used to have one venue to attack a brand patent: federal district court, under a clear-and-convincing-evidence
How to Use PTAB Data to Predict Which Brand Patents Will Crumble Read Post »
DISH Technologies LLC v. MW Media (SC), SC|2:26-cv-00508: Litigation Summary, Claims, and IP Risk Analysis DISH Technologies LLC v. MW
DISH Technologies LLC v. MW Media SC Read Post »
DISH Technologies L.L.C. v. DAZN US LLC (1:26-cv-00604): Litigation Summary, Claims Likely at Issue, and IP/Business Risk Analysis What is
DISH Technologies L.L.C. v. DAZN US LLC Read Post »
DISH Technologies LLC v. Fenix International Limited (2:26-cv-00547): Litigation Summary, Claims, and Outcome Scenarios DISH Technologies LLC sued Fenix International
DISH Technologies LLC v. Fenix International Limited Read Post »
AbbVie v. Annora Pharma Private Limited (1:26-cv-00688): litigation status, claims at issue, and Paragraph IV/ANDA risk mapping What is AbbVie
AbbVie Inc. v. Annora Pharma Private Limited Read Post »
Vertex Pharmaceuticals v. MSN Pharmaceuticals (1:26-cv-00306): Litigation Summary, Claims at Issue, and Near-Term Patent/ANDA Exposure Vertex Pharmaceuticals Incorporated sued MSN
Vertex Pharmaceuticals Incorporated v. MSN Pharmaceuticals Inc. Read Post »
Get fresh news and insights, drug patent expirations & more…